Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3039765, 10 pages
https://doi.org/10.1155/2017/3039765
Research Article

Resistin as a Prooxidant Factor and Predictor of Endothelium Damage in Patients with Mild Acute Pancreatitis Exposed to Tobacco Smoke Xenobiotics

1Department of Biomedical and Environmental Analysis, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland
2Second Department of General and Oncological Surgery, Wroclaw Medical University, Wroclaw, Poland

Correspondence should be addressed to Milena Ściskalska; lp.corw.demu@akslaksics.anelim and Halina Milnerowicz; lp.corw.demu@zciworenlim.anilah

Received 7 March 2017; Accepted 27 July 2017; Published 26 September 2017

Academic Editor: Mirella Giovarelli

Copyright © 2017 Milena Ściskalska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Milnerowicz, M. Ściskalska, and M. Dul, “Pro-inflammatory effects of metals in persons and animals exposed to tobacco smoke,” Journal of Trace Elements in Medicine and Biology, vol. 29, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Sliwińska-Mossoń, M. Sciskalska, P. Karczewska-Górska, and H. Milnerowicz, “The effect of endothelin-1 on pancreatic diseases in patients who smoke,” Advances in Clinical and Experimental Medicine, vol. 22, no. 5, pp. 745–752, 2013. View at Google Scholar
  3. S. Halappanavar, M. Russell, M. R. Stampfli, A. Williams, and C. L. Yauk, “Induction of the interleukin 6/signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke,” BMC Medical Genomics, vol. 2, no. 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. B. Koo and J.-S. Han, “Cigarette smoke extract-induced interleukin-6 expression is regulated by phospholipase D1 in human bronchial epithelial cells,” The Journal of Toxicological Sciences, vol. 41, no. 1, pp. 77–89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. S. Park, J. Kim, Y. Misonou et al., “Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 6, pp. 1319–1325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. U. A. Wittel, U. T. Hopt, and S. K. Batra, “Cigarette smoke-induced pancreatic damage—experimental data,” Langenbeck's Archives of Surgery, vol. 393, no. 4, pp. 581–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Topsakal, O. Ozmen, R. Aslankoc, and D. H. Aydemir, “Pancreatic damage induced by cigarette smoke: the specific pathological effects of cigarette smoke in the rat model,” Toxicology Research, vol. 5, no. 3, pp. 938–945, 2016. View at Google Scholar
  8. N. Momi, S. Kaur, M. P. Ponnusamy, S. Kumar, U. A. Wittel, and S. K. Batra, “Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis,” Carcinogenesis, vol. 33, no. 9, pp. 1617–1628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Edderkaoui and E. Thrower, “Smoking and pancreatic disease,” Journal of Cancer Therapy, vol. 04, no. 10, pp. 34–40, 2013. View at Publisher · View at Google Scholar
  10. S. G. Barreto, “How does cigarette smoking cause acute pancreatitis?” Pancreatology, vol. 16, no. 2, pp. 157–163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Staubli, D. Oertli, and C. A. Nebiker, “Laboratory markers predicting severity of acute pancreatitis,” Critical Reviews in Clinical Laboratory Sciences, vol. 52, no. 6, pp. 273–283, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. E. C. Lewis, “Expanding the clinical indications for α(1)-antitrypsin therapy,” Molecular Medicine (Cambridge, Mass.), vol. 18, pp. 957–970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Fournier, N. Medjoubi-N, and D. Porquet, “Alpha-1-acid glycoprotein,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1482, no. 1-2, pp. 157–171, 2000. View at Google Scholar
  14. A. Sarrats, R. Saldova, E. Pla et al., “Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis,” Proteomics. Clinical Applications, vol. 4, no. 4, pp. 432–448, 2010. View at Publisher · View at Google Scholar
  15. W. P. Petros, I. R. Younis, J. N. Ford, and S. A. Weed, “Effects of tobacco smoking and nicotine on cancer treatment,” Pharmacotherapy, vol. 32, no. 10, pp. 920–931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Rajendran, T. Rengarajan, J. Thangavel et al., “The vascular endothelium and human diseases,” International Journal of Biological Sciences, vol. 9, no. 10, pp. 1057–1069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Milnerowicz, H. Milnerowicz, S. Nabzdyk, M. Jabłonowska, K. Grabowski, and R. Taboła, “Plasma endothelin-1 levels in pancreatic inflammations,” Advances in Clinical and Experimental Medicine, vol. 22, no. 3, pp. 361–368, 2013. View at Google Scholar
  18. K. M. Barnes and J. L. Miner, “Role of resistin in insulin sensitivity in rodents and humans,” Current Protein & Peptide Science, vol. 10, no. 1, pp. 96–107, 2009. View at Google Scholar
  19. M. S. Jamaluddin, S. M. Weakley, Q. Yao, and C. Chen, “Resistin: functional roles and therapeutic considerations for cardiovascular disease: resistin and cardiovascular disease,” British Journal of Pharmacology, vol. 165, no. 3, pp. 622–632, 2012. View at Google Scholar
  20. Y. I. Kibar, F. Albayrak, M. Arabul, H. Dursun, Y. Albayrak, and Y. Ozturk, “Resistin: new serum marker for predicting severity of acute pancreatitis,” The Journal of International Medical Research, vol. 44, no. 2, pp. 328–337, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. E. C. Paulino, L. J. d. Souza, N. A. T. Molan, M. C. C. Machado, and S. Jancar, “Neutrophils from acute pancreatitis patients cause more severe in vitro endothelial damage compared with neutrophils from healthy donors and are differently regulated by endothelins,” Pancreas, vol. 35, no. 1, pp. 37–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Liu, X. Hou, Q. Zhou et al., “Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody,” Free Radical Research, vol. 45, no. 6, pp. 662–671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Selmeci, “Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?” Free Radical Research, vol. 45, no. 10, pp. 1115–1123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sciskalska, M. Zalewska, A. Grzelak, and H. Milnerowicz, “The influence of the occupational exposure to heavy metals and tobacco smoke on the selected oxidative stress markers in smelters,” Biological Trace Element Research, vol. 159, no. 1–3, pp. 59–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Publisher · View at Google Scholar
  26. Z. Wang, L. Ni, J. Wang et al., “The protective effect of melatonin on smoke-induced vascular injury in rats and humans: a randomized controlled trial,” Journal of Pineal Research, vol. 60, no. 2, pp. 217–227, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Panek, J. Zasada, and M. Poźniczek, “Microcirculatory disturbance in the course of acute pancreatitis,” Przegla̧d Lekarski, vol. 64, no. 6, pp. 435–437, 2007. View at Google Scholar
  28. M. Hermoso de Mendoza García, D. Hernández Moreno, F. Soler Rodríguez, A. López Beceiro, L. E. Fidalgo Alvarez, and M. Pérez López, “Sex- and age-dependent accumulation of heavy metals (Cd, Pb and Zn) in liver, kidney and muscle of roe deer (Capreolus capreolus) from NW Spain,” Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering, vol. 46, no. 2, pp. 109–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Yasuda, K. Yoshida, Y. Yasuda, and T. Tsutsui, “Two age-related accumulation profiles of toxic metals,” Current Aging Science, vol. 5, no. 2, pp. 105–111, 2012. View at Google Scholar
  30. M. Śliwińska-Mossoń, H. Milnerowicz, M. Jabłonowska, S. Milnerowicz, S. Nabzdyk, and J. Rabczyński, “The effect of smoking on expression of IL-6 and antioxidants in pancreatic fluids and tissues in patients with chronic pancreatitis,” Pancreatology, vol. 12, no. 4, pp. 295–304, 2012. View at Google Scholar
  31. R. E. Lamb and B. J. Goldstein, “Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function: modulating an oxidative-inflammatory cascade,” International Journal of Clinical Practice, vol. 62, no. 7, pp. 1087–1095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Sánchez-Bernal, O. H. García-Morales, C. Domínguez et al., “Nitric oxide protects against pancreatic subcellular damage in acute pancreatitis,” Pancreas, vol. 28, no. 1, pp. e9–e15, 2004. View at Google Scholar
  33. C. C. Winterbourn, M. J. D. Bonham, H. Buss, F. M. Abu-Zidan, and J. A. Windsor, “Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis,” Pancreatology, vol. 3, no. 5, pp. 375–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Rau, B. Poch, F. Gansauge et al., “Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?” Annals of Surgery, vol. 231, no. 3, pp. 352–360, 2000. View at Google Scholar
  35. J. H. Yu and H. Kim, “Oxidative stress and inflammatory signaling in cerulein pancreatitis,” World Journal of Gastroenterology, vol. 20, no. 46, article 17324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Gruys, M. J. M. Toussaint, T. A. Niewold, and S. J. Koopmans, “Acute phase reaction and acute phase proteins,” Journal of Zhejiang University Science, vol. 6B, no. 11, pp. 1045–1056, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P. D. Anderson, N. N. Mehta, M. L. Wolfe et al., “Innate immunity modulates adipokines in humans,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2272–2279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski, “Resistin, an adipokine with potent proinflammatory properties,” Journal of Immunology (Baltimore, Md. : 1950), vol. 174, no. 9, pp. 5789–5795, 2005. View at Publisher · View at Google Scholar
  39. M. Filková, M. Haluzík, S. Gay, and L. Šenolt, “The role of resistin as a regulator of inflammation: implications for various human pathologies,” Clinical Immunology, vol. 133, no. 2, pp. 157–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Kaser, A. Kaser, A. Sandhofer, C. F. Ebenbichler, H. Tilg, and J. R. Patsch, “Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro,” Biochemical and Biophysical Research Communications, vol. 309, no. 2, pp. 286–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Lehrke, M. P. Reilly, S. C. Millington, N. Iqbal, D. J. Rader, and M. A. Lazar, “An inflammatory cascade leading to hyperresistinemia in humans,” PLoS Medicine, vol. 1, no. 2, article e45, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Daniel, B. Leśniowski, A. Mokrowiecka, A. Jasińska, M. Pietruczuk, and E. Małecka-Panas, “Circulating levels of visfatin, resistin and pro-inflammatory cytokine interleukin-8 in acute pancreatitis,” Pancreatology, vol. 10, no. 4, pp. 477–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. L.-N. Xue, X.-Y. Wang, Y. Tan, M. Lin, W. Zhang, and K.-Q. Xu, “Significance of resistin expression in acute pancreatitis,” Experimental and Therapeutic Medicine, vol. 9, no. 4, pp. 1438–1442, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Yu, S. Wang, Z. Qiu et al., “Efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis,” Pancreatology, vol. 16, no. 6, pp. 952–957, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Daniel, B. Leśniowski, A. Jasińska, M. Pietruczuk, and E. Małecka-Panas, “Usefulness of assessing circulating levels of resistin, ghrelin, and IL-18 in alcoholic acute pancreatitis,” Digestive Diseases and Sciences, vol. 55, no. 10, pp. 2982–2987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Karpavicius, Z. Dambrauskas, A. Gradauskas et al., “The clinical value of adipokines in predicting the severity and outcome of acute pancreatitis,” BMC Gastroenterology, vol. 16, no. 1, p. 99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. A. L. Esquivel, J. Pérez-Ramos, J. Cisneros et al., “The effect of obesity and tobacco smoke exposure on inflammatory mediators and matrix metalloproteinases in rat model,” Toxicology Mechanisms and Methods, vol. 24, no. 9, pp. 633–643, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Kawanami, K. Maemura, N. Takeda et al., “Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions,” Biochemical and Biophysical Research Communications, vol. 314, no. 2, pp. 415–419, 2004. View at Google Scholar
  49. H. Mu, R. Ohashi, S. Yan et al., “Adipokine resistin promotes in vitro angiogenesis of human endothelial cells,” Cardiovascular Research, vol. 70, no. 1, pp. 146–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Verma, S. H. Li, C. H. Wang et al., “Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction,” Circulation, vol. 108, no. 6, pp. 736–740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. L. F. Rodella, G. Favero, C. Rossini, E. Foglio, R. J. Reiter, and R. Rezzani, “Endothelin-1 as a potential marker of melatonin’s therapeutic effects in smoking-induced vasculopathy,” Life Sciences, vol. 87, no. 17-18, pp. 558–564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Santilli, R. Liani, P. Di Fulvio et al., “Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus,” Thrombosis and Haemostasis, vol. 116, no. 6, 2016. View at Publisher · View at Google Scholar · View at Scopus